Spontaneous Resolution of Intravitreal Steroid-Induced Bilateral Cytomegalovirus Retinitis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 73-year-old woman underwent vitrectomy and intravitreal triamcinolone acetonide (IVTA) of the right eye and cataract surgery with IVTA of the left eye, for bilateral diabetic macular edema. The patient presented with visual loss in both eyes three-months postoperatively. The fundoscopic examination revealed white-yellow, necrotic peripheral lesions in the superotemporal quadrant of both eyes. Although bilateral acute retinal necrosis was suspected, azotemia resulting from diabetic nephropathy limited the use of acyclovir. Antiviral treatment was not started. A sample of the aqueous humor for polymerase chain reaction (PCR) analysis was obtained. One week later, the PCR results indicated the presence of cytomegalovirus (CMV). Since the retinal lesions did not progress and did not threaten the macula, the patient was followed without treatment for CMV. The retinal lesions progressively regressed and completely resolved in both eyes by six months of follow-up. Patients with IVTA-induced CMV retinitis may not require systemic treatment with ganciclovir.
Abstract
A 73-year-old woman underwent vitrectomy and intravitreal triamcinolone acetonide (IVTA) of the right eye and cataract surgery with IVTA of the left eye, for bilateral diabetic macular edema. The patient presented with visual loss in both eyes three-months postoperatively. The fundoscopic examination revealed white-yellow, necrotic peripheral lesions in the superotemporal quadrant of both eyes. Although bilateral acute retinal necrosis was suspected, azotemia resulting from diabetic nephropathy limited the use of acyclovir. Antiviral treatment was not started. A sample of the aqueous humor for polymerase chain reaction (PCR) analysis was obtained. One week later, the PCR results indicated the presence of cytomegalovirus (CMV). Since the retinal lesions did not progress and did not threaten the macula, the patient was followed without treatment for CMV. The retinal lesions progressively regressed and completely resolved in both eyes by six months of follow-up. Patients with IVTA-induced CMV retinitis may not require systemic treatment with ganciclovir.
참고문헌 (28)
- Wiegand TW, "Cytomegalovirus retinitis", IntOphthalmol Clin, 46, pp.91~110 (2006)
- Saidel MA, "Cytomegalovirus retinitisafter intravitreous triamcinolone in an immunocompetentpatient", Am J Ophthalmol, 140, pp.1141~1143 (2005)
- Delyfer MN, "Cytomegalovirusretinitis following intravitreal injection oftriamcinolone: report of two cases", Acta Ophthalmol Scand, 85, pp.681~683 (2007)
- Sekiryu T, "Cytomegalovirusretinitis after intravitreal triamcinolone acetonide in an immunocompetentpatient", Jpn J Ophthalmol, 52, pp.414~416 (2008)
- YongSik Park, "Cytomegalovirus Retinitis After Intravitreous Triamcinolone Injection in a Patient with Central Retinal Vein Occlusion", Korean Journal of Ophthalmology, 22(2), pp.143~144 (2008), 대한안과학회
- Ufret-Vincenty RL, "Cytomegalovirus retinitis after fluocinolone acetonide (Retisert)implant", Am J Ophthalmol, 143, pp.334~335 (2007)
- Noffke AS, "Spontaneous resolution of cytomegalovirusretinitis in an infant with congenital cytomegalovirusinfection", Retina, 21, pp.541~542 (2001)
- Whitcup SM, "Spontaneous and sustained resolution of CMV retinitis inpatients receiving highly active antiretroviral therapy", Br JOphthalmol, 82, pp.845~846 (1998)
- Taylor-Wiedeman J, "Monocytes are a major site of persistence of humancytomegalovirus in peripheral blood mononuclear cells", JGen Virol, 72(Pt 9), pp.2059~2064 (1991)
- Bevan IS, "Polymerase chain reactionfor detection of human cytomegalovirus infection in ablood donor population", Br J Haematol, 78, pp.94~99 (1991)
- Stanier P, "Detection ofhuman cytomegalovirus in peripheral mononuclear cellsand urine samples using PCR", Mol Cell Probes, 6, pp.51~58 (1992)
- Docke WD, "Cytomegalovirus reactivationand tumour necrosis factor", Lancet, 343, pp.268~269 (1994)
- Kondo K, "Human cytomegaloviruslatent gene expression in granulocyte-macrophage progenitorsin culture and in seropositive individuals", Proc NatlAcad Sci U S A, 93, pp.11137~11142 (1996)
- Mendelson M, "Detection ofendogenous human cytomegalovirus in CD34+ bone marrowprogenitors", J Gen Virol, 77(Pt 12), pp.3099~3102 (1996)
- Fish KN, "Human cytomegaloviruspersistently infects aortic endothelial cells", JVirol, 72, pp.5661~5668 (1998)
- Fish KN, "Cytomegaloviruspersistence in macrophages and endothelial cells", Scand J Infect Dis Suppl, 99, pp.34~40 (1995)
- Chen R, "The relationship betweenhuman cytomegalovirus infection and atherosclerosis development", Mol Cell Biochem, 249, pp.91~96 (2003)
- Speir E, "Potential role of humancytomegalovirus and p53 interaction in coronary restenosis", Science, 265, pp.391~394 (1994)
- Rabinovitch T, "In vivo reactivation oflatent murine cytomegalovirus in the eye by immunosuppressivetreatment", Invest Ophthalmol Vis Sci, 31, pp.657~663 (1990)
- Vogel JU, "The human eye(retina): a site of persistent HCMV infection?", Graefes ArchClin Exp Ophthalmol, 243, pp.671~676 (2005)
- Halary F, "Human cytomegalovirusbinding to DC-SIGN is required for dendriticcell infection and target cell trans-infection", Immunity, 17, pp.653~664 (2002)
- Skiest DJ, "Cytomegalovirus retinitis in the era of highlyactive antiretroviral therapy (HAART)", Am J Med Sci, 317, pp.318~335 (1999)
- Read RW, "Evaluation ofthe role of human retinal vascular endothelial cells in thepathogenesis of CMV retinitis", Ocul Immunol Inf lamm, 7, pp.139~146 (1999)
- Beer PM, "Intraocular concentrationand pharmacokinetics of triamcinolone acetonide aftera single intravitreal injection", Ophthalmology, 110, pp.681~686 (2003)
- Mason JO 3rd, "Intravitreal concentrationand clearance of triamcinolone acetonide in nonvitrectomizedhuman eyes", Retina, 24, pp.900~904 (2004)
- Lake KD, "Ganciclovir pharmacokineticsduring renal impairment", Antimicrob AgentsChemother, 32, pp.1899~1900 (1988)
- McGavin JK, "Ganciclovir: an update of its use inthe prevention of cytomegalovirus infection and disease intransplant recipients", Drugs, 61, pp.1153~1183 (2001)
- Whitcup SM, "Therapeuticeffect of combination antiretroviral therapy on cytomegalovirusretinitis", JAMA, 277, pp.1519~1520 (1997)